These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9315042)

  • 21. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
    Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J
    J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999.
    Syhakhang L; Lundborg CS; Lindgren B; Tomson G
    Pharm World Sci; 2004 Dec; 26(6):333-8. PubMed ID: 15683103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria.
    Ndichu ET; Ohiri K; Sekoni O; Makinde O; Schulman K
    PLoS One; 2019; 14(2):e0211567. PubMed ID: 30759124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India.
    Seear M; Gandhi D; Carr R; Dayal A; Raghavan D; Sharma N
    J Clin Pharm Ther; 2011 Aug; 36(4):488-95. PubMed ID: 21729113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of anti-malaria agent chloroquine using single drop liquid-liquid-liquid microextraction.
    Daneshfar A; Khezeli T; Manafi MH
    J Sep Sci; 2009 Feb; 32(4):511-6. PubMed ID: 19173322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of quinine and chloroquine anti-malarial agents in pharmaceuticals and biological fluids by HPLC and fluorescence detection.
    Samanidou VF; Evaggelopoulou EN; Papadoyannis IN
    J Pharm Biomed Anal; 2005 Jun; 38(1):21-8. PubMed ID: 15907614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines.
    Gaudiano MC; Antoniella E; Bertocchi P; Valvo L
    J Pharm Biomed Anal; 2006 Sep; 42(1):132-5. PubMed ID: 16517111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro evaluation of marketed antimalarial chloroquine phosphate tablets.
    Patel AK; Prajapati BG; Moria RS; Patel CN
    J Vector Borne Dis; 2005 Dec; 42(4):147-50. PubMed ID: 16457384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication.
    Basco LK
    Am J Trop Med Hyg; 2004 Mar; 70(3):245-50. PubMed ID: 15031511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies.
    Wang T; Hoag SW; Eng ML; Polli J; Pandit NS
    J Clin Pharm Ther; 2015 Feb; 40(1):68-75. PubMed ID: 25381836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of essential drugs in tropical countries: evaluation of antimalarial drugs in the Brazilian Health System.
    Nogueira FH; Moreira-Campos LM; Santos RL; Pianetti GA
    Rev Soc Bras Med Trop; 2011 Oct; 44(5):582-6. PubMed ID: 22031073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions to improve the use of antimalarials in south-east Asia: an overview.
    Gomes M; Wayling S; Pang L
    Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):9-19. PubMed ID: 9763718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries.
    Macquart de Terline D; Diop BI; Bernard M; Do B; Ikama MS; N'guetta R; Balde DM; Tchabi Y; Sidi Aly A; Ali Toure I; Zabsonre P; Damorou JF; Takombe JL; Narayanan K; Fernandez C; Tafflet M; Plouin PF; Empana JP; Marijon E; Jouven X; Antignac M
    J Hypertens; 2018 Feb; 36(2):395-401. PubMed ID: 28957849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.
    Lalani M; Kaur H; Mohammed N; Mailk N; Wyk AV; Jan S; Kakar RM; Mojadidi MK; Leslie T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):51-58. PubMed ID: 25897070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.